2026 Lung Cancer Update

Join the Nebraska Oncology Society for a live event on Saturday, November 14 for this year’s fourth and final presentation of its 2026 Speaker Series. This event will feature the topic of “Lung Cancer Update” and will take place from 7:30am-11:00am CDT at the

We look forward to offering you these latest updates.

Agenda:

7:30-8:30AM- Registration, Breakfast & Exhibitors

8:30- 8:35AM- Welcome & Introduction

8:35-9:35AM- Presentation & Q/A- Key Updates in the Treatment of Non-Small Cell Lung Cancer

9:35-9:50AM- Break & Exhibitors

9:50-10:50AM- Presentation & Q/A- Key Updates in the Treatment of Small Cell Lung Cancer

10:50AM- Closing Remarks

Presentation 1 & 2

Accreditation

The Nebraska Medical Education Trust designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Joint Sponsorship

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Nebraska Medical Education Trust and Nebraska Oncology Society. The Nebraska Medical Education Trust is accredited by the Nebraska Medical Association to provide continuing medical education for physicians.

Astellas

Astrazeneca

Deciphera

Lilly Oncology

 

Gilead

Merck

Pfizer